GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prestige BioPharma Ltd (XKRX:950210) » Definitions » Price-to-Operating-Cash-Flow

Prestige BioPharma (XKRX:950210) Price-to-Operating-Cash-Flow : (As of Jun. 04, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Prestige BioPharma Price-to-Operating-Cash-Flow?

As of today (2025-06-04), Prestige BioPharma's share price is ₩13270.00. Prestige BioPharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-1,148.35. Hence, Prestige BioPharma's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Prestige BioPharma's Price-to-Operating-Cash-Flow or its related term are showing as below:

XKRX:950210's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 24.27
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Prestige BioPharma's Cash Flow from Operations per share for the three months ended in Dec. 2024 was ₩-412.54. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-1,148.35.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -38.80% per year.

During the past 5 years, Prestige BioPharma's highest 3-Year average Operating Cash Flow per Share Growth Rate was -38.80% per year. The lowest was -51.20% per year. And the median was -45.00% per year.


Prestige BioPharma Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Prestige BioPharma's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prestige BioPharma Price-to-Operating-Cash-Flow Chart

Prestige BioPharma Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24
Price-to-Operating-Cash-Flow
- - - - -

Prestige BioPharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Prestige BioPharma's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Prestige BioPharma's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prestige BioPharma's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Prestige BioPharma's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Prestige BioPharma's Price-to-Operating-Cash-Flow falls into.


;
;

Prestige BioPharma Price-to-Operating-Cash-Flow Calculation

Prestige BioPharma's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=13270.00/-1148.346
=

Prestige BioPharma's Share Price of today is ₩13270.00.
Prestige BioPharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,148.35.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Prestige BioPharma Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Prestige BioPharma's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Prestige BioPharma Business Description

Traded in Other Exchanges
N/A
Address
2 Science Park Drive No. 04-13/14, Ascent Tower B, Singapore Science Park, Singapore, SGP, 118222
Prestige BioPharma Ltd is a biopharmaceutical company. The company is focused on the development of biosimilars and new antibody therapeutics. It focuses on oncology and immune disorders, developing new and similar antibody drugs for solid tumor, pancreatic cancer, and arthritis.

Prestige BioPharma Headlines

No Headlines